Oxidative stress and diabetic complications
By Ferdinando Giacco, M. Brownlee. Circulation Research, 2010
2,670 citations recorded by the source corpus.
Oxidative stress plays a pivotal role in the development of diabetes complications, both microvascular and cardiovascular. The metabolic abnormalities of diabetes cause mitochondrial superoxide overproduction in endothelial cells of both large and small vessels, and also in the myocardium. This increased superoxide production causes the activation of five major pathways involved in the pathogenesis of complications: polyol pathway flux, increased formation of advanced glycation end-products (AGEs), increased expression of the receptor for AGEs and its activating ligands, activation of protein kinase C (PKC) isoforms, and overactivity of the hexosamine pathway. It also directly inactivates two critical antiatherosclerotic enzymes, eNOS and prostacyclin synthase. Through these pathways, increased intracellular ROS cause defective angiogenesis in response to ischemia, activate a number of pro-inflammatory pathways, and cause long-lasting epigenetic changes which drive persistent expression of proinflammatory genes after glycemia is normalized (‘hyperglycemic memory’). Atherosclerosis and cardiomyopathy in type 2 diabetes are caused in part by pathway-selective insulin resistance, which increases mitochondrial ROS production from free fatty acids and by inactivation of anti-atherosclerosis enzymes by ROS. Overexpression of superoxide dismutase in transgenic diabetic mice prevents diabetic retinopathy, nephropathy, and cardiomyopathy. The aim of this review is to highlight advances in understanding the role of metabolite-generated ROS in the development of diabetic complications.
Subfields: Clinical Biochemistry, Endocrinology, Diabetes and Metabolism
View Paper: https://www.semanticscholar.org/paper/051d2e7bd948bdc3434c508f2e9ea2f206b84882
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Biochemistry
In Endocrinology, Diabetes and Metabolism
Citations in the corpus
- Pathophysiology of Type 2 Diabetes Mellitus (2020, background): “Through these pathways, increased intracellular ROS causes defective angiogenesis in response to ischemia, activates a number of proinflammatory pathways, and cause long-lasting epigenetic changes which drive persistent expression of proinflammatory genes even after glycemia is normalized [58].”
- Skin Acute Wound Healing: A Comprehensive Review (2019, background): “Diabetes hyperglycemia disrupts the homeostasis of glucose metabolism in endothelial cells, neurons, Schwann cells, and peripheral blood mononuclear cells (PBMC) because these cells are not able to reduce the intracellular glucose transport in the presence of hyperglycemia [168].”
- Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? (2016, positive): “[55] Hyperglycemia itself stimulates oxidative stress, which indeed acts as a driving force in accelerated atherosclerosis.”
- Association between insulin resistance and the development of cardiovascular disease (2018, background): “Moreover, changes produced by glucose fluctuations and hyperglycemia can induce long-lasting epigenetic modifications in the promoter of the NF-κB, which appears to be mediated by increased oxidative stress [132].”
- The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation (2020, background): “Studies in vitro have demonstrated that increased ROS production is linked to hyperglycemia [50].”